comparemela.com
Home
Live Updates
Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 ... : comparemela.com
Werewolf Therapeutics Announces WTX-124 Clinical Abstract Accepted for Presentation at the 2024 ...
Company to present an update of its ongoingmonotherapy and combinationPhase 1/1b study of WTX-124 in advanced or metastatic solid tumors
Related Keywords
United States
,
Chicago
,
Illinois
,
Watertown
,
American
,
Josh Rappaport
,
Ellen Lubman
,
Company Contact
,
Company Or Werewolf Nasdaq
,
Scientific Communications
,
Exchange Commission
,
Werewolf Therapeutics Inc
,
American Society Of Clinical Oncology
,
Clinical Oncology
,
Annual Meeting
,
Non Hodgkin Lymphoma
,
Private Securities Litigation Reform Act
,
Region
,
comparemela.com © 2020. All Rights Reserved.